Form 4: Synopsys Executive Aart de Geus Reports Stock Transactions
SEC Form 4 Filing
Aart de Geus, Executive Chair of Synopsys, reports the acquisition and disposition of common stock and restricted stock units on March 15, 2024.
Summary
- On March 15, 2024, Aart de Geus, the Executive Chair of Synopsys, engaged in transactions involving Synopsys common stock and restricted stock units.
- De Geus acquired 1,764 shares of common stock through the vesting of restricted stock units.
- 610 shares were disposed of to cover tax withholding obligations related to the vesting of the restricted stock units at a price of $550.03 per share.
- Following these transactions, de Geus directly owns 106,983 shares of common stock.
- De Geus also indirectly owns 122,226 shares through a Family Trust, 14,500 shares through a Partnership, and 186,551 shares through a Separate Property Trust.
- He also holds 5,290 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in the technology industry.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they relate to executive compensation and do not indicate a significant change in company outlook.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of stock transactions (acquisition and disposition) and vesting of restricted stock units. |
| 03/15/2027 | Expiration date of the restricted stock units. |
| 03/19/2024 | Date of the report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.